The Global Amikacin Sulfate API Market was valued at USD 177 Million in 2025 and is projected to reach USD 238 Million by 2034, growing at a Compound Annual Growth Rate (CAGR) of 4.4% during the forecast period (2024–2034). This sustained growth is driven by the escalating global incidence of multi-drug resistant Gram-negative bacterial infections, increasing surgical procedures requiring prophylactic care, and the critical role of amikacin as a last-line defense antibiotic in healthcare settings worldwide.

As the pharmaceutical industry intensifies its focus on antimicrobial stewardship and combating antibiotic resistance, the spotlight is on the key Active Pharmaceutical Ingredient (API) manufacturers ensuring a robust and high-quality supply of this essential aminoglycoside. In this blog, we profile the Top 10 Companies in the Amikacin Sulfate API Industry—a mix of established chemical giants and specialized pharmaceutical producers shaping the future of infectious disease treatment.

Download FREE Sample Report:
Amikacin Sulfate API Market – View in Detailed Research Report

---

🔟 1. ACS DOBFAR SPA

Headquarters: Tribiano, Milan, Italy
Key Offering: High-Purity Amikacin Sulfate API (Purity ≥99%)

ACS DOBFAR SPA is a leading international pharmaceutical group specializing in the development and production of active pharmaceutical ingredients and finished dosage forms, with a strong focus on antibiotics. The company’s state-of-the-art manufacturing facilities are certified by major global regulatory bodies, including the FDA and EMA, ensuring compliance with stringent Good Manufacturing Practice (GMP) standards.

Strategic Initiatives:

• Significant investment in R&D for process optimization and impurity profile control.

• Strategic partnerships with generic pharmaceutical companies across Europe, Asia, and the Americas.

• Commitment to sustainable manufacturing practices and reducing environmental impact.

---

9️⃣ 2. SHANDONG ANXIN PHARMACEUTICAL CO LTD

Headquarters: Heze City, Shandong Province, China
Key Offering: Amikacin Sulfate API for Injection and Suspension formulations

As a major player in China’s pharmaceutical API market, SHANDONG ANXIN PHARMACEUTICAL has established a strong reputation for the production of aminoglycoside antibiotics. The company leverages advanced synthesis technologies and rigorous quality control systems to supply both domestic and international markets, contributing significantly to the global amikacin supply chain.

Strategic Initiatives:

• Expansion of production capacity to meet growing global demand.

• Focus on cost-efficiency while maintaining high-quality standards.

---

8️⃣ 3. Zhejiang Jinhua Kangenba Biopharmaceutical Co., Ltd.

Headquarters: Jinhua, Zhejiang Province, China
Key Offering: Amikacin Sulfate API, Pharmaceutical Intermediates

Zhejiang Jinhua Kangenba Biopharmaceutical specializes in the research, production, and sale of pharmaceutical intermediates and APIs, with amikacin sulfate being a core product. The company’s integrated manufacturing approach ensures control over the entire production process, from raw materials to the final API, enhancing supply chain reliability.

Strategic Initiatives:

• Continuous process improvement to enhance yield and purity.

• Development of eco-friendly synthesis routes.

---

7️⃣ 4. Sichuan Ren’an Pharmaceutical

Headquarters: Sichuan Province, China
Key Offering: Amikacin Sulfate API (Various Grades)

Sichuan Ren’an Pharmaceutical is a recognized manufacturer of chemical pharmaceuticals and APIs in Western China. The company has developed robust expertise in the fermentation and chemical synthesis processes required for aminoglycoside production, positioning it as a key supplier in the Asian market.

Strategic Initiatives:

• Investment in modern analytical equipment for enhanced quality assurance.

• Exploration of new market opportunities in emerging economies.

Download FREE Sample Report:
Amikacin Sulfate API Market – View in Detailed Research Report

---

6️⃣ 5. Jiangsu Wuzhong Pharmaceutical Group Co., Ltd. Suzhou Pharmaceutical Factory

Headquarters: Suzhou, Jiangsu Province, China
Key Offering: Amikacin Sulfate API, Finished Dosage Forms

This entity is part of the larger Jiangsu Wuzhong Pharmaceutical Group, a comprehensive pharmaceutical enterprise. The Suzhou facility is dedicated to the production of high-quality APIs, including amikacin sulfate, and benefits from the group’s extensive resources and distribution network.

Strategic Initiatives:

• Vertical integration from API to finished product manufacturing.

• Strengthening regulatory filings for international market access.

---

5️⃣ 6. Zhejiang Yongning Pharmaceutical

Headquarters: Taizhou, Zhejiang Province, China
Key Offering: Amikacin Sulfate API, Sterile Products

Zhejiang Yongning Pharmaceutical is a technologically advanced manufacturer with a diverse portfolio of APIs and finished pharmaceuticals. The company places a strong emphasis on the production of sterile APIs, which is critical for injectable formulations of amikacin, ensuring patient safety and compliance with pharmacopeial standards.

Strategic Initiatives:

• Specialization in sterile API manufacturing technologies.

• Building long-term supply agreements with multinational pharmaceutical companies.

---

4️⃣ 7. Livzon Group Fuzhou Fuxing Pharmaceutical

Headquarters: Fuzhou, Fujian Province, China
Key Offering: Amikacin Sulfate API, Broad-spectrum Antibiotics

As part of the prominent Livzon Pharmaceutical Group, Fuzhou Fuxing Pharmaceutical leverages the group’s extensive research capabilities and market presence. The company has a well-established track record in antibiotic manufacturing and maintains a significant market share in the amikacin API segment.

Strategic Initiatives:

• Utilization of group-level R&D for process innovation.

• Strategic focus on portfolio diversification within the anti-infective segment.

---

3️⃣ 8. Peking University Pharmaceutical Chongqing Daxin Pharmaceutical

Headquarters: Chongqing, China
Key Offering: Amikacin Sulfate API, Pharmaceutical Chemicals

This company benefits from its academic affiliation, fostering a strong culture of innovation and quality. It is engaged in the production of a range of pharmaceutical chemicals, with amikacin sulfate representing a key therapeutic agent in its portfolio, supplied to formulation manufacturers globally.

Strategic Initiatives:

• Collaboration with academic institutions for research advancements.

• Focus on maintaining a competitive cost structure.

---

2️⃣ 9. Chengdu Best Pharmaceutical

Headquarters: Chengdu, Sichuan Province, China
Key Offering: Amikacin Sulfate API (Purity ≥99% and Purity<99%)

Chengdu Best Pharmaceutical is a specialized manufacturer of pharmaceutical intermediates and APIs. The company offers amikacin sulfate in different purity grades to cater to the specific requirements of various formulation developers, demonstrating flexibility and a customer-centric approach.

Strategic Initiatives:

• Custom synthesis capabilities for specific client needs.

• Active pursuit of certifications from emerging market regulatory authorities.

---

1️⃣ 10. Other Key Regional Players

Headquarters: Various Global Locations
Key Offering: Amikacin Sulfate API, Generic APIs

Beyond the top listed companies, the market includes several other significant regional manufacturers and emerging players located in India, Europe, and other parts of Asia. These companies contribute to market diversity, ensure supply chain resilience, and often compete on price and regional regulatory expertise, providing essential options for pharmaceutical companies sourcing amikacin sulfate API.

Market Role:

• Fill niche market demands and ensure geographic supply redundancy.

• Drive competitive pricing and innovation in manufacturing processes.

Get Full Report Here:
Amikacin Sulfate API Market – View in Detailed Research Report

---

🌍 Outlook: The Future of Amikacin Sulfate API Involves Precision and Stewardship

The Amikacin Sulfate API market is navigating a critical juncture. While demand remains strong due to its irreplaceable role in treating resistant infections, the industry is increasingly focused on antimicrobial stewardship, supply chain robustness, and advanced manufacturing techniques to ensure sustainable access.

📈 Key Trends Shaping the Market:

• Increasing regulatory scrutiny on API quality and impurity profiles, especially for injectable products.

• Strategic stockpiling of essential antibiotics by governments and health organizations to mitigate supply chain disruptions.

• Growing adoption of Quality by Design (QbD) principles in API manufacturing to ensure consistent quality.

• Rising importance of environmental, social, and governance (ESG) criteria in supplier selection by large pharmaceutical companies.

Get Full Report Here:
Amikacin Sulfate API Market – View in Detailed Research Report

The companies listed above are not only supplying a critical medical ingredient—they are upholding a vital line of defense in the global fight against antimicrobial resistance.